61 related articles for article (PubMed ID: 24815086)
21. Association of apolipoprotein E gene polymorphism with ischemic stroke involving large-vessel disease and its relation to serum lipid levels.
Saidi S; Slamia LB; Ammou SB; Mahjoub T; Almawi WY
J Stroke Cerebrovasc Dis; 2007; 16(4):160-6. PubMed ID: 17689412
[TBL] [Abstract][Full Text] [Related]
22. Apolipoprotein A5 gene IVS3+G476A allelic variant confers susceptibility for development of ischemic stroke.
Maasz A; Kisfali P; Jaromi L; Horvatovich K; Szolnoki Z; Csongei V; Safrany E; Sipeky C; Hadarits F; Melegh B
Circ J; 2008 Jul; 72(7):1065-70. PubMed ID: 18577813
[TBL] [Abstract][Full Text] [Related]
23. Association study of Apolipoprotein A5 gene (APOA5 gene) variant with the metabolic syndrome in local Pakistani population.
Fiaz M; Shaiq PA; Raj GK; Saqlain M; Mehmood A; Naqvi SMS; Cheung BK
J Pak Med Assoc; 2019 Mar; 69(3):301-305. PubMed ID: 30890818
[TBL] [Abstract][Full Text] [Related]
24. Apolipoprotein E genotypes and metabolic risk factors for coronary heart disease in middle-aged women.
Cubrilo-Turek M; Stavljenić-Rukavina A; Sertić J; Zrinski R; Turek S; Grgac G; Ljubojević N
Coll Antropol; 1998 Jun; 22(1):149-55. PubMed ID: 10097431
[TBL] [Abstract][Full Text] [Related]
25. Isoforms of apolipoprotein E can modulate tPA-induced clot lysis in vitro.
Clark JF; Huri DA; Carrozzella J; Jauch EC; Mehta P; Heaton D; Biehle SJ; Broderick JP
Front Biosci; 2002 Aug; 7():a163-8. PubMed ID: 12133811
[TBL] [Abstract][Full Text] [Related]
26. Apolipoprotein E polymorphism in the Tunisian population: frequency and effect on lipid parameters.
Jemaa R; Elasmi M; Naouali C; Feki M; Kallel A; Souissi M; Sanhaji H; Hadj Taïeb S; Souheil O; Kaabachi N
Clin Biochem; 2006 Aug; 39(8):816-20. PubMed ID: 16714010
[TBL] [Abstract][Full Text] [Related]
27. Apolipoprotein E gene polymorphisms are strong predictors of inflammation and dyslipidemia in rheumatoid arthritis.
Toms TE; Smith JP; Panoulas VF; Blackmore H; Douglas KM; Kitas GD
J Rheumatol; 2012 Feb; 39(2):218-25. PubMed ID: 22174202
[TBL] [Abstract][Full Text] [Related]
28. Apolipoprotein A5 polymorphisms and risk of coronary artery disease: a meta-analysis.
Zhang Z; Peng B; Gong RR; Gao LB; Du J; Fang DZ; Song YY; Li YH; Ou GJ
Biosci Trends; 2011 Aug; 5(4):165-72. PubMed ID: 21914952
[TBL] [Abstract][Full Text] [Related]
29. The interaction of Apolipoprotein A5 gene promoter region T-1131C polymorphism (rs12286037) and lifestyle modification on plasma triglyceride levels in Japanese.
Yamasaki M; Mutombo PB; Iwamoto M; Nogi A; Hashimoto M; Nabika T; Shiwaku K
Nutr Res Pract; 2015 Aug; 9(4):379-84. PubMed ID: 26244076
[TBL] [Abstract][Full Text] [Related]
30. The dyslipidemia-associated SNP on the APOA1/C3/A5 gene cluster predicts post-surgery poor outcome in Taiwanese breast cancer patients: a 10-year follow-up study.
Hsu MC; Lee KT; Hsiao WC; Wu CH; Sun HY; Lin IL; Young KC
BMC Cancer; 2013 Jul; 13():330. PubMed ID: 23829168
[TBL] [Abstract][Full Text] [Related]
31. Apolipoprotein A5 S19W may play a role in dysbetalipoproteinemia in patients with the Apo E2/E2 genotype.
Martín-Campos JM; Rico N; Bonet R; Mayoral C; Ordóñez-Llanos J; Blanco-Vaca F
Clin Chem; 2006 Oct; 52(10):1974-5. PubMed ID: 16998123
[No Abstract] [Full Text] [Related]
32. A possible role of apolipoprotein E polymorphism in predisposition to higher education.
Hubacek JA; Pitha J; Skodová Z; Adámková V; Lánská V; Poledne R
Neuropsychobiology; 2001; 43(3):200-3. PubMed ID: 11287800
[TBL] [Abstract][Full Text] [Related]
33. Rare variant of apolipoprotein E (Arg136 -->Ser) in two normolipidemic individuals.
Hubácek JA; Adámková V; Skodová Z
Physiol Res; 2005; 54(5):573-5. PubMed ID: 15641930
[TBL] [Abstract][Full Text] [Related]
34. Identification of a New Single-nucleotide Polymorphism within the Apolipoprotein A5 Gene, Which is Associated with Metabolic Syndrome.
Salehi S; Emadi-Baygi M; Rezaei M; Kelishadi R; Nikpour P
Adv Biomed Res; 2017; 6():24. PubMed ID: 28401071
[TBL] [Abstract][Full Text] [Related]
35. Apolipoprotein E genotype and sex influence C-reactive protein levels regardless of exercise training status.
Angelopoulos TJ; Miles MP; Lowndes J; Sivo SA; Seip RL; Pescatello LS; Zoeller RF; Visich PS; Gordon PM; Moyna NM; Thompson PD
Metabolism; 2008 Sep; 57(9):1204-10. PubMed ID: 18702945
[TBL] [Abstract][Full Text] [Related]
36. Hyperlipidemia in patients with apolipoprotein E 2/2 phenotype: apolipoprotein A5 S19W mutation as a cofactor.
Schaefer JR; Sattler AM; Hackler B; Kurt B; Hackler R; Maisch B; Soufi M
Clin Chem; 2004 Nov; 50(11):2214. PubMed ID: 15502102
[No Abstract] [Full Text] [Related]
37. Prevalence of the apolipoprotein E Arg145Cys dyslipidemia at-risk polymorphism in African-derived populations.
Abou Ziki MD; Strulovici-Barel Y; Hackett NR; Rodriguez-Flores JL; Mezey JG; Salit J; Radisch S; Hollmann C; Chouchane L; Malek J; Zirie MA; Jayyuosi A; Gotto AM; Crystal RG
Am J Cardiol; 2014 Jan; 113(2):302-8. PubMed ID: 24239320
[TBL] [Abstract][Full Text] [Related]
38. THE ASSOCIATION BETWEEN PRO AND ANTI-INFLAMMATORY MARKERS WITH THE COMPONENTS OF METABOLIC SYNDROME.
Kir S; Ekiz K; Alacam H; Turkel R; Koroglu E; Altintop BL
Acta Endocrinol (Buchar); 2019; 15(4):430-435. PubMed ID: 32377238
[TBL] [Abstract][Full Text] [Related]
39. Apolipoprotein A5-12238 T>C gene polymorphism and risk factors for metabolic syndrome in the Guo Shan Yao and the Han populations.
He F; Xu X; Hu D; Ma S; Tang L; Fan W; Chen B; Zhou J; Ma Z
Clin Chem Lab Med; 2011 Oct; 49(10):1755-7. PubMed ID: 21707471
[No Abstract] [Full Text] [Related]
40. Proteinuria and severe mixed dyslipidemia associated with a novel APOAV gene mutation.
Soran H; Charlton-Menys V; Hegele R; Wang J; Benbow EW; Roberts I; Wood G; Durrington P
J Clin Lipidol; 2010; 4(4):310-3. PubMed ID: 21122665
[No Abstract] [Full Text] [Related]
[Previous] [Next] [New Search]
